Search

Elli Peselev

Examiner (ID: 18809)

Most Active Art Unit
1623
Art Unit(s)
1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899
Total Applications
2819
Issued Applications
1829
Pending Applications
143
Abandoned Applications
853

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 817144 [patent_doc_number] => 07410952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Derivatives of azithromycin' [patent_app_type] => utility [patent_app_number] => 10/552318 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2999 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/410/07410952.pdf [firstpage_image] =>[orig_patent_app_number] => 10552318 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/552318
Derivatives of azithromycin Apr 15, 2004 Issued
Array ( [id] => 7466384 [patent_doc_number] => 20040198715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Methods of administering dalbavancin for treatment of skin and soft tissue infections' [patent_app_type] => new [patent_app_number] => 10/828483 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23215 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198715.pdf [firstpage_image] =>[orig_patent_app_number] => 10828483 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828483
Methods of administering dalbavancin for treatment of skin and soft tissue infections Apr 15, 2004 Abandoned
Array ( [id] => 7605365 [patent_doc_number] => 07115564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Stable pharmaceutical compositions of dalbavancin and methods of administration' [patent_app_type] => utility [patent_app_number] => 10/828439 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22979 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115564.pdf [firstpage_image] =>[orig_patent_app_number] => 10828439 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828439
Stable pharmaceutical compositions of dalbavancin and methods of administration Apr 15, 2004 Issued
Array ( [id] => 7377859 [patent_doc_number] => 20040220122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Methods of administering dalbavancin for treatment of bacterial infections' [patent_app_type] => new [patent_app_number] => 10/828379 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23219 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220122.pdf [firstpage_image] =>[orig_patent_app_number] => 10828379 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828379
Methods of administering dalbavancin for treatment of bacterial infections Apr 15, 2004 Abandoned
Array ( [id] => 7346662 [patent_doc_number] => 20040192622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Stabilized azithromycin compositions' [patent_app_type] => new [patent_app_number] => 10/822773 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8589 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192622.pdf [firstpage_image] =>[orig_patent_app_number] => 10822773 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/822773
Stabilized azithromycin compositions Apr 12, 2004 Abandoned
Array ( [id] => 7264966 [patent_doc_number] => 20040242502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Semi-synthetic saponin analogs with carrier and immune stimulatory activities for DNA and RNA vaccines' [patent_app_type] => new [patent_app_number] => 10/820036 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15937 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242502.pdf [firstpage_image] =>[orig_patent_app_number] => 10820036 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/820036
Semi-synthetic saponin analogs with carrier and immune stimulatory activities for DNA and RNA vaccines Apr 7, 2004 Abandoned
Array ( [id] => 5096155 [patent_doc_number] => 20070117764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials' [patent_app_type] => utility [patent_app_number] => 10/550359 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3530 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117764.pdf [firstpage_image] =>[orig_patent_app_number] => 10550359 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550359
Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials Apr 1, 2004 Abandoned
Array ( [id] => 5242882 [patent_doc_number] => 20070021377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Pharmaceutical composition comprising a macrolide immunomodulator' [patent_app_type] => utility [patent_app_number] => 10/550356 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3344 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021377.pdf [firstpage_image] =>[orig_patent_app_number] => 10550356 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550356
Pharmaceutical composition comprising a macrolide immunomodulator Apr 1, 2004 Abandoned
10/816376 ETHANOLATE OF AZITHROMYCIN, PROCESS FOR MANUFACTURE, AND PHARMACEUTICAL COMPOSITIONS THEREOF Apr 1, 2004 Abandoned
Array ( [id] => 7434339 [patent_doc_number] => 20040266699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Flavonoid compounds capable of modifying the dynamic and/or physical state of biological membranes and to stimulate the endogenous synthesis of stress proteins in eukaryotic cells, relative synthesis and their use' [patent_app_type] => new [patent_app_number] => 10/491612 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7212 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266699.pdf [firstpage_image] =>[orig_patent_app_number] => 10491612 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/491612
Flavonoid compounds capable of modifying the dynamic and/or physical state of biological membranes and to stimulate the endogenous synthesis of stress proteins in eukaryotic cells, relative synthesis and their use Apr 1, 2004 Abandoned
Array ( [id] => 5000361 [patent_doc_number] => 20070042995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria' [patent_app_type] => utility [patent_app_number] => 10/550784 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2098 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042995.pdf [firstpage_image] =>[orig_patent_app_number] => 10550784 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550784
Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria Mar 28, 2004 Abandoned
Array ( [id] => 7672937 [patent_doc_number] => 20040180842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => '4\"-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives' [patent_app_type] => new [patent_app_number] => 10/810922 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17623 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180842.pdf [firstpage_image] =>[orig_patent_app_number] => 10810922 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/810922
4″-substituted-9-deoxo-9a-aza-9a-homoerythromycin A derivatives Mar 25, 2004 Issued
Array ( [id] => 7437765 [patent_doc_number] => 20040266997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Degradation products of azithromycin, and methods for their indentification' [patent_app_type] => new [patent_app_number] => 10/809065 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4421 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266997.pdf [firstpage_image] =>[orig_patent_app_number] => 10809065 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/809065
Degradation products of azithromycin, and methods for their indentification Mar 24, 2004 Abandoned
Array ( [id] => 7276329 [patent_doc_number] => 20040235780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Pharmaceutical composition of antiviral agents' [patent_app_type] => new [patent_app_number] => 10/809250 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7662 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235780.pdf [firstpage_image] =>[orig_patent_app_number] => 10809250 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/809250
Pharmaceutical composition of antiviral agents Mar 24, 2004 Abandoned
Array ( [id] => 7351395 [patent_doc_number] => 20040248824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Method for controlling beetles' [patent_app_type] => new [patent_app_number] => 10/490587 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8395 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248824.pdf [firstpage_image] =>[orig_patent_app_number] => 10490587 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/490587
Method for controlling beetles Mar 24, 2004 Abandoned
Array ( [id] => 6959341 [patent_doc_number] => 20050215519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products' [patent_app_type] => utility [patent_app_number] => 10/808409 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12521 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215519.pdf [firstpage_image] =>[orig_patent_app_number] => 10808409 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/808409
Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products Mar 24, 2004 Abandoned
Array ( [id] => 7329833 [patent_doc_number] => 20040254126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => '11-12 Bicyclic erythromycin derivatives' [patent_app_type] => new [patent_app_number] => 10/806748 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45122 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254126.pdf [firstpage_image] =>[orig_patent_app_number] => 10806748 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/806748
11-12 Bicyclic erythromycin derivatives Mar 22, 2004 Abandoned
Array ( [id] => 628309 [patent_doc_number] => RE039383 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2006-11-07 [patent_title] => 'Process for 6-O-alkylation of erythromycin derivatives' [patent_app_type] => reissue [patent_app_number] => 10/806089 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5978 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039383.pdf [firstpage_image] =>[orig_patent_app_number] => 10806089 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/806089
Process for 6-O-alkylation of erythromycin derivatives Mar 21, 2004 Issued
Array ( [id] => 554502 [patent_doc_number] => 07160866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-09 [patent_title] => 'Isolation of tigogenin pentaglycoside from Chlorophytum nimonii' [patent_app_type] => utility [patent_app_number] => 10/806065 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4155 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/160/07160866.pdf [firstpage_image] =>[orig_patent_app_number] => 10806065 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/806065
Isolation of tigogenin pentaglycoside from Chlorophytum nimonii Mar 21, 2004 Issued
Array ( [id] => 5678534 [patent_doc_number] => 20060183890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Isopropanolate of azithromycin and method of manufacturing' [patent_app_type] => utility [patent_app_number] => 10/550104 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2197 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183890.pdf [firstpage_image] =>[orig_patent_app_number] => 10550104 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550104
Isopropanolate of azithromycin and method of manufacturing Mar 18, 2004 Abandoned
Menu